{"id":527140,"date":"2026-07-01T06:29:08","date_gmt":"2026-07-01T06:29:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/527140\/"},"modified":"2026-07-01T06:29:08","modified_gmt":"2026-07-01T06:29:08","slug":"ai-cancer-imaging-tool-could-improve-bone-disease-monitoring-in-prostate-cancer-and-multiple-myeloma","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/527140\/","title":{"rendered":"AI cancer imaging tool could improve bone disease monitoring in prostate cancer and multiple myeloma"},"content":{"rendered":"

The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech company\u00a0Mint Medical<\/a>, a Snke Company, to improve monitoring for patients with bone disease in advanced prostate cancer and multiple myeloma.<\/p>\n

Following a long-running collaboration, an AI algorithm created by researchers and clinicians at The Institute of Cancer Research (ICR) and\u00a0The Royal Marsden\u00a0<\/a>has been integrated into Mint Medical\u2019s mint Lesion software.\u00a0As a result of the agreement, Mint Medical can now offer this AI-powered software to healthcare providers globally.<\/p>\n

Using AI to improve bone imaging<\/p>\n

The new software was developed to improve the visualization of cancer growing inside bones, using a type of MRI called diffusion-weighted imaging, or DWI.<\/p>\n

DWI is especially useful in scanning patients with prostate cancer and multiple myeloma.\u00a0In prostate cancer, secondary tumors, also known as metastases, can develop in the bone. In multiple myeloma the original, or primary, tumors develop in the bone marrow.\u00a0The software helps to pin-point areas of bone disease, as well as whether the disease is getting better or worse with treatment.<\/p>\n

It could make bone disease assessment more standardized and accurate for patients \u2013 saving patients and healthcare providers time and money.<\/p>\n

Translating innovation to patient benefit<\/p>\n

The new software builds on expertise developed at the ICR and The Royal Marsden over several years, during which they have pioneered improvements to whole-body DWI with the aim of improving its speed and accuracy \u2013 including through this collaboration with Mint Medical.<\/p>\n

Funders of this research have included the\u00a0National Institute for Health and Care Research (NIHR)<\/a>, which supported it both via Invention for Innovation (i4i) grants and The Royal Marsden and the ICR\u2019s joint NIHR Biomedical Research Centre (BRC), the ICR, which is itself a charity, and The Royal Marsden Cancer Charity and Cancer Research UK.<\/p>\n

The initial results of the integration of the ICR-Royal Marsden-developed algorithm into mint Lesion have already been announced at major medical conferences and\u00a0published in scientific journals<\/a>.<\/p>\n

\u2018This software will improve the lives of patients with advanced disease\u2019<\/p>\n

Dr Matthew Blackledge<\/a>, Group Leader in Computational Imaging at The Institute of Cancer Research, London, said:\u00a0\u201cOur innovations in AI have provided us with an opportunity to detect the presence of disease within DWI with unprecedented speed and accuracy.<\/p>\n

\u201cA core motivation for all our group\u2019s research is to translate our findings into patient benefit. By working closely with Mint Medical, we have been able to deliver clinical software that will improve the lives of patients with advanced disease.\u201d<\/p>\n

\u2018Our goal is to help patients stay well for longer\u2019<\/p>\n

Professor Dow-Mu Koh,<\/a> Consultant Radiologist in Functional Imaging at The Royal Marsden NHS Foundation Trust and Professor in Functional Cancer Imaging at The Institute of Cancer Research, London, said:\u00a0\u201cAssessment of cancer-related bone disease remains an unmet clinical need. Our software, designed for use alongside whole-body MRI, can help determine whether a patient is responding to treatment.<\/p>\n

\u201cBy improving the sensitivity of treatment assessment, we may also be able to identify earlier when a treatment is not effective and switch patients to alternative therapies more quickly. Ultimately, the goal is to help patients stay well for longer.\u201d<\/p>\n

Dr Matthias Baumhauer, Managing Director at Mint Medical, said:\u00a0\u201cThis collaboration with The Institute of Cancer Research and The Royal Marsden is more than a development project for us \u2013 it is the connection of high-quality clinical research with our technology. I am proud of what we have achieved together: a solution that provides radiology with an objective, reproducible tool where previously it was difficult to achieve anything beyond a rough, subjective estimate.\u201d<\/p>\n

Dr Jon Wilkinson,<\/a> Director of Business and Innovation at The Institute of Cancer Research, London, said:\u00a0\u201cThis collaboration is a powerful demonstration of what\u2019s possible when world-class researchers and clinicians at the ICR and The Royal Marsden join forces with innovative partners like Mint Medical. It reflects our mission in action \u2013 turning cutting-edge discovery into real patient benefit, through purposeful collaboration.\u201d<\/p>\n

This article has been republished from the\u00a0following\u00a0materials<\/a>.\u00a0Material may have been edited for length and house style. For further information, please contact the cited source. Our press release publishing policy can be accessed\u00a0here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust have announced a new licensing…\n","protected":false},"author":2,"featured_media":527141,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[218,61,60,106669,345,80],"class_list":["post-527140","post","type-post","status-publish","format-standard","has-post-thumbnail","category-technology","tag-artificial-intelligence","tag-ie","tag-ireland","tag-multiple-myeloma","tag-prostate-cancer","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/527140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=527140"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/527140\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/527141"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=527140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=527140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=527140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}